CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market buy President & CEO bought 60,000 shares at $2.45 ($146,814)
- 4 Grant or award President & CEO acquired 40,000 shares (grant or award)
- 4 Grant or award EVP & Chief Business Officer acquired 12,500 shares (grant or award)
- 4 Grant or award EVP & Chief Medical Officer acquired 12,500 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 12,500 shares (grant or award)
- 4 Grant or award EVP & Chief Scientific Officer acquired 12,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise President & CEO acquired 100,942 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President & CEO sold 7,500 shares at $22.05 ($165,341)
- 4 Open-market sale EVP & Chief Scientific Officer sold 16,190 shares at $20.00 ($323,860)
- 4 Open-market sale EVP & Chief Financial Officer sold 3,500 shares at $20.01 ($70,034)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President & CEO sold 7,500 shares at an average $22.43 ($168,230)
- 4 Open-market sale EVP & Chief Scientific Officer sold 15,000 shares at an average $21.49 ($322,325)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 11 · 206 filings